MPs welcome NAO investigation of UK-US pharma deal
By Lee Peart 04 November 2026
The Health and Social Committee has welcomed news the National Audit Office (NAO) will examine the long-term financial implications on the NHS of the UK-US pharmaceuticals deal.
Multi-Systemic Therapy Team Supervisor
£48,072 - £54,994 per annum
Crewe, Cheshire£48,072 - £54,994 per annum
Assistant Director: Integrated Community Support
£89,862 - £103,472
Blaenau Gwent and Torfaen£89,862 - £103,472
Head of Health Determinants Research Collaboration
£69,151 - £73,937
Pontypool & Ebbw Vale£69,151 - £73,937
Most Read News
- BREAKING NEWS: Five-year settlement rights given to health and care workers
- Mackey says NHS years away from meeting A&E waiting time target
- UK health agency investigates population exposure to 'forever chemicals'
- Tech firm's collapse impacts hundreds of GP practices
- ICB cuts must deliver savings and protect skills, NAO warns
Multi-Systemic Therapy Team Supervisor
£48,072 - £54,994 per annum
Crewe, Cheshire£48,072 - £54,994 per annum
Assistant Director: Integrated Community Support
£89,862 - £103,472
Blaenau Gwent and Torfaen£89,862 - £103,472
Head of Health Determinants Research Collaboration
£69,151 - £73,937
Pontypool & Ebbw Vale£69,151 - £73,937
Most Read News
- BREAKING NEWS: Five-year settlement rights given to health and care workers
- Mackey says NHS years away from meeting A&E waiting time target
- UK health agency investigates population exposure to 'forever chemicals'
- Tech firm's collapse impacts hundreds of GP practices
- ICB cuts must deliver savings and protect skills, NAO warns
©2026 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
